| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,952 |
1,830 |
$93K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,021 |
869 |
$79K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
565 |
479 |
$38K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
452 |
427 |
$34K |
| 90686 |
|
2,721 |
2,591 |
$27K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,595 |
1,504 |
$19K |
| 96127 |
|
1,132 |
1,054 |
$17K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
836 |
697 |
$16K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
204 |
182 |
$15K |
| 90677 |
|
104 |
88 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
68 |
65 |
$6K |
| 90670 |
|
382 |
326 |
$4K |
| 90656 |
|
261 |
259 |
$4K |
| 90734 |
|
133 |
102 |
$2K |
| 90647 |
|
144 |
107 |
$2K |
| 90723 |
|
111 |
81 |
$2K |
| 90715 |
|
62 |
41 |
$871.12 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14 |
14 |
$494.62 |
| 90716 |
|
14 |
14 |
$477.50 |
| 90633 |
|
49 |
49 |
$439.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13 |
13 |
$406.90 |
| 90707 |
|
15 |
15 |
$396.16 |
| 90698 |
|
42 |
37 |
$361.38 |
| 90680 |
|
14 |
12 |
$237.30 |
| 90651 |
|
17 |
16 |
$102.40 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
33 |
30 |
$36.00 |
| 90461 |
|
12 |
12 |
$0.00 |